The PLK1 inhibitor onvansertib overcomes irinotecan resistance in RAS-mutated (mRAS) metastatic colorectal cancer (mCRC) in vivo and in patients (pts)

Kopetz, S; Ridinger, M; Sorokin, A; Kanikarla, P; Gao, F; Liu, Z; Samuelsz, E; Smeal, T; Starr, JS; Sharma, MR

ANNALS OF ONCOLOGY, 2022; 33 (7): S704

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索